Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galectins and Ovarian Cancer.
Shimada C, Xu R, Al-Alem L, Stasenko M, Spriggs DR, Rueda BR. Shimada C, et al. Among authors: spriggs dr. Cancers (Basel). 2020 May 31;12(6):1421. doi: 10.3390/cancers12061421. Cancers (Basel). 2020. PMID: 32486344 Free PMC article. Review.
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
Zhang S, Yan C, Millar DG, Yang Q, Heather JM, Langenbucher A, Morton LT, Sepulveda S, Alpert E, Whelton LR, Zarrella DT, Guo M, Minogue E, Lawrence MS, Rueda BR, Spriggs DR, Lu W, Langenau DM, Cobbold M. Zhang S, et al. Among authors: spriggs dr. Cancer Res. 2022 Mar 1;82(5):773-784. doi: 10.1158/0008-5472.CAN-21-2200. Cancer Res. 2022. PMID: 34965933
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission.
O'Cearbhaill RE, Ragupathi G, Zhu J, Wan Q, Mironov S, Yang G, Spassova MK, Iasonos A, Kravetz S, Ouerfelli O, Spriggs DR, Danishefsky SJ, Sabbatini PJ. O'Cearbhaill RE, et al. Among authors: spriggs dr. Cancers (Basel). 2016 Apr 22;8(4):46. doi: 10.3390/cancers8040046. Cancers (Basel). 2016. PMID: 27110823 Free PMC article.
Ovarian Cancer Treatment - Are We Getting Warmer?
Spriggs DR, Zivanovic O. Spriggs DR, et al. N Engl J Med. 2018 Jan 18;378(3):293-294. doi: 10.1056/NEJMe1714556. N Engl J Med. 2018. PMID: 29342385 No abstract available.
New agents for the treatment of ovarian cancer: the next generation.
Dupont J, Aghajanian C, Sabbatini P, Spriggs DR. Dupont J, et al. Among authors: spriggs dr. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:252-7. doi: 10.1111/j.1525-1438.2005.00443.x. Int J Gynecol Cancer. 2005. PMID: 16343241 Free article. Review.
PARP Inhibitors in Ovarian Cancer Treatment.
Spriggs DR, Longo DL. Spriggs DR, et al. N Engl J Med. 2016 Dec 1;375(22):2197-2198. doi: 10.1056/NEJMe1612843. N Engl J Med. 2016. PMID: 27959768 No abstract available.
Progress in BRCA-Mutated Ovarian Cancer.
Spriggs DR, Longo DL. Spriggs DR, et al. N Engl J Med. 2018 Dec 27;379(26):2567-2568. doi: 10.1056/NEJMe1812644. N Engl J Med. 2018. PMID: 30586521 No abstract available.
278 results